poisar

Stock

West Pharmaceutical Services, Inc. WST

$350.17+0.48%

Overview

WST market data

Price History

WST price chart · 1M
O
347.97
H
352.80
L
347.97
C
350.17
Vol
22,810.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$347.97
Previous Close
$348.50
Day High
$352.80
Day Low
$347.97
52 Week High
$382.87
52 Week Low
$228.08
7 Day Return
-0.60%
30 Day Return
+5.81%
90 Day Return
+8.78%
1 Year Return
+42.63%
Daily Notional Volume
$8M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
43.89
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$6.79
Diluted earnings per share over the trailing twelve months.
Beta
1.13
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
0.3%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
17.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$223.83 – $386.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $24.8B · P/B 6.23 · P/S 7.45.

Company News

10 captured
Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock UpZacks Investment Research · Aug 27, 2026, 6:00 PM
Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412Benzinga · Aug 3, 2026, 6:52 PM
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $425Benzinga · Jul 27, 2026, 2:51 PM
West Pharmaceutical CEO Highlights GLP-1 And Biologics MomentumBenzinga · Jul 23, 2026, 3:32 PM
Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings CallBenzinga · Jul 23, 2026, 1:22 PM
West Pharmaceutical Services shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also, the company raised its FY26 guidance above estimates.Benzinga · Jul 23, 2026, 12:45 PM
8-K filing — WEST PHARMACEUTICAL SERVICES INC (WST)SEC EDGAR · Jul 23, 2026, 11:14 AM
Earnings Scheduled For July 23, 2026Benzinga · Jul 23, 2026, 11:11 AM
West Pharmaceutical Servs Raises FY2026 Adj EPS Guidance from $8.40-$8.75 to $8.85-$9.05 vs $8.61 Est; Raises FY2026 Sales Guidance from $3.295B-$3.350B to $3.345B-$3.380B vs $3.332B EstBenzinga · Jul 23, 2026, 10:09 AM
West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $8.15-$8.50 to $8.85-$9.05 vs $8.41 EstBenzinga · Jul 23, 2026, 10:08 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock